Meridiem Capital Partners’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
DM
B
VCM
GS
Meridiem Capital Partners's CDNA Position: Q1 2026 in Review
Meridiem Capital Partners opened a new position in CareDx (CDNA) in Q1 2026: 316,950 shares worth $5.5M. The stake represents 0.36% of the portfolio and ranks #61 among its holdings. This is a return to the name: Meridiem Capital Partners previously reported a position in CDNA as recently as Q2 2025.
Meridiem Capital Partners first reported a position in CDNA in Q2 2025 and has held it in 2 quarters since. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.
- Meridiem Capital Partners held 316,950 shares of CareDx worth $5.5M as of Q1 2026.
- CareDx was a new Meridiem Capital Partners position in Q1 2026.
- CareDx made up 0.36% of Meridiem Capital Partners's portfolio in Q1 2026, its #61 holding.
- Meridiem Capital Partners first reported a position in CareDx in Q2 2025 and has held it in 2 quarters since.
- 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.
Based on Meridiem Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.